Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 5
1982 4
1983 2
1984 5
1985 10
1986 10
1987 9
1988 11
1989 12
1990 4
1991 4
1992 8
1993 5
1994 3
1995 2
1996 4
1997 2
1998 5
1999 2
2000 5
2001 2
2002 10
2003 9
2004 5
2005 7
2006 6
2007 7
2008 18
2009 13
2010 14
2011 19
2012 24
2013 23
2014 26
2015 25
2016 18
2017 18
2018 18
2019 18
2020 18
2021 12
2022 9
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Results by year

Filters applied: . Clear all
Page 1
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L; DANAMI-3—PRIMULTI Investigators. Engstrøm T, et al. Among authors: kelbaek h. Lancet. 2015 Aug 15;386(9994):665-71. doi: 10.1016/s0140-6736(15)60648-1. Lancet. 2015. PMID: 26347918 Clinical Trial.
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
Valgimigli M, Wlodarczak A, Tölg R, Merkely B, Kelbæk H, Legutko J, Galli S, Godin M, Toth GG, Lhermusier T, Honton B, Dietrich PL, Stammen F, Ferdinande B, Silvain J, Capodanno D, Cayla G; Bioflow-DAPT Investigators. Valgimigli M, et al. Among authors: kelbaek h. Circulation. 2023 Sep 26;148(13):989-999. doi: 10.1161/CIRCULATIONAHA.123.065448. Epub 2023 Aug 25. Circulation. 2023. PMID: 37624364 Free PMC article. Clinical Trial.
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial.
Landi A, Heg D, Frigoli E, Vranckx P, Windecker S, Siegrist P, Cayla G, Włodarczak A, Cook S, Gómez-Blázquez I, Feld Y, Seung-Jung P, Mates M, Lotan C, Gunasekaran S, Nanasato M, Das R, Kelbæk H, Teiger E, Escaned J, Ishibashi Y, Montalescot G, Matsuo H, Debeljacki D, Smits PC, Valgimigli M; MASTER DAPT Investigators. Landi A, et al. Among authors: kelbaek h. JACC Cardiovasc Interv. 2023 Apr 10;16(7):798-812. doi: 10.1016/j.jcin.2023.01.366. JACC Cardiovasc Interv. 2023. PMID: 37045500 Free article. Clinical Trial.
To defer, or not to defer, that is the question.
Kelbæk H, Høfsten DE, Engstrøm T. Kelbæk H, et al. EuroIntervention. 2017 Jul 20;13(4):381-382. doi: 10.4244/EIJV13I4A58. EuroIntervention. 2017. PMID: 28735249 Free article. No abstract available.
[Hypertrophic cardiomyopathy].
Bundgaard H, Havndrup O, Høst U, Kelbaek H. Bundgaard H, et al. Among authors: kelbaek h. Ugeskr Laeger. 1998 Sep 14;160(38):5478-83. Ugeskr Laeger. 1998. PMID: 9763919 Review. Danish.
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial.
Jolicoeur EM, Dendukuri N, Belisle P, Range G, Souteyrand G, Bouisset F, Zemour G, Delarche N, Harbaoui B, Schampaert E, Kouz S, Cayla G, Roubille F, Boueri Z, Mansour S, Marcaggi X, Tardif JC, McGillion M, Tanguay JF, Brophy J, Yu CW, Berry C, Carrick D, Høfsten DE, Engstrøm T, Kober L, Kelbæk H, Belle L. Jolicoeur EM, et al. Among authors: kelbaek h. Can J Cardiol. 2020 Nov;36(11):1805-1814. doi: 10.1016/j.cjca.2020.01.019. Epub 2020 Jan 25. Can J Cardiol. 2020. PMID: 32798463 Review.
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation. De Luca G, et al. Among authors: kelbaek h. Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Arch Intern Med. 2012. PMID: 22529227 Review.
Coronary Artery Disease Detected by Low Frequency Heart Sounds.
Schmidt SE, Madsen LH, Hansen J, Zimmermann H, Kelbæk H, Winter S, Hammershøi D, Toft E, Struijk JJ, Clemmensen P. Schmidt SE, et al. Among authors: kelbaek h. Cardiovasc Eng Technol. 2022 Dec;13(6):864-871. doi: 10.1007/s13239-022-00622-6. Epub 2022 May 11. Cardiovasc Eng Technol. 2022. PMID: 35545751
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Stettler C, et al. Among authors: kelbaek h. Lancet. 2007 Sep 15;370(9591):937-48. doi: 10.1016/S0140-6736(07)61444-5. Lancet. 2007. PMID: 17869634 Review.
387 results